{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:12Z","timestamp":1753891932331,"version":"3.41.2"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Children with underlying medical conditions potentially develop severe illness from Coronavirus disease 2019 (COVID-19). The use of vaccines against COVID-19 is currently recommended for the pediatric population. The COVID-19 vaccine has a temporal association with the occurrence of myocarditis. Although most patients with COVID-19 vaccination-associated myocarditis (C-VAM) exhibit a mild clinical course and rapid recovery, C-VAM potentially causes electrical instability and sudden cardiac death. Herein, we report the case of a 17-year-old woman who presented with chest pain and syncope following the first dose of the messenger RNA COVID-19 vaccine. The patient's heart function was impaired, and nonsustained ventricular tachycardia was frequent. Cardiac magnetic resonance (CMR) imaging satisfied the criteria for myocarditis. Despite the administration of immunomodulatory drugs, the patient's heart function was not fully restored, and the concentration of cardiac enzymes remained above the normal range. Persistence of late gadolinium enhancement was observed on short-term follow-up CMR imaging. Although most patients with C-VAM exhibit mild symptoms, significant cardiac arrhythmias potentially occur. Furthermore, some patients with C-VAM demonstrate prolonged impaired heart function and sustained late gadolinium enhancement on follow-up CMR imaging. Therefore, monitoring of electrical and functional cardiac abnormalities in patients with C-VAM is crucial and the long-term outcomes and prognosis of patients with C-VAM require further investigation.<\/jats:p>","DOI":"10.3389\/fped.2022.995167","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T06:45:35Z","timestamp":1669013135000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report: Myocarditis with nonsustained ventricular tachycardia following COVID-19 mRNA vaccination in a female adolescent"],"prefix":"10.3389","volume":"10","author":[{"given":"Jeongho","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joowon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Hwan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e215298","DOI":"10.1001\/jamanetworkopen.2021.5298","article-title":"Characteristics and disease severity of US children and adolescents diagnosed with COVID-19","volume":"4","author":"Preston","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa2102605","article-title":"Multisystem inflammatory syndrome in children\u2014initial therapy and outcomes","volume":"385","author":"Son","year":"2021","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa2203315","article-title":"Evaluation of mRNA-1273 COVID-19 vaccine in children 6 to 11 years of age","volume":"386","author":"Creech","year":"2022","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa2116298","article-title":"Evaluation of the BNT162b2 COVID-19 vaccine in children 5 to 11 years of age","volume":"386","author":"Walter","year":"2022","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.15585\/mmwr.mm7045e1","article-title":"The advisory committee on immunization practices\u2019 interim recommendation for use of pfizer-BioNTech COVID-19 vaccine in children aged 5\u201311 years\u2014United States, november 2021","volume":"70","author":"Woodworth","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/cid\/ciab989","article-title":"Epidemiology of acute myocarditis\/pericarditis in Hong Kong adolescents following comirnaty vaccination","volume":"75","author":"Chua","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jpeds.2021.07.044","article-title":"Myopericarditis after messenger RNA coronavirus disease 2019 vaccination in adolescents 12 to 18 years of age","volume":"238","author":"Das","year":"2021","journal-title":"J Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jamacardio.2021.3471","article-title":"Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children","volume":"6","author":"Dionne","year":"2021","journal-title":"JAMA Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2021053427","DOI":"10.1542\/peds.2021-053427","article-title":"COVID-19 vaccination-associated myocarditis in adolescents","volume":"148","author":"Jain","year":"2021","journal-title":"Pediatrics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e2021052478","DOI":"10.1542\/peds.2021-052478","article-title":"Symptomatic acute myocarditis in 7 adolescents after pfizer-BioNTech COVID-19 vaccination","volume":"148","author":"Marshall","year":"2021","journal-title":"Pediatrics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1097\/INF.0000000000003389","article-title":"Population-based incidence of myopericarditis after COVID-19 vaccination in danish adolescents","volume":"41","author":"Nygaard","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.3390\/ijerph19063456","article-title":"COVID-19-vaccination-induced myocarditis in teenagers: case series with further follow-up","volume":"19","author":"Puchalski","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jpeds.2022.03.032","article-title":"Persistent cardiac magnetic resonance imaging findings in a cohort of adolescents with post-coronavirus disease 2019 mRNA vaccine myopericarditis","volume":"245","author":"Schauer","year":"2022","journal-title":"J Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1097\/INF.0000000000003235","article-title":"Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine","volume":"40","author":"Snapiri","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/jpids\/piab060","article-title":"Perimyocarditis in adolescents after pfizer-BioNTech COVID-19 vaccine","volume":"10","author":"Tano","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1161\/CIRCULATIONAHA.121.056583","article-title":"Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: suspected myocarditis after COVID-19 vaccination","volume":"145","author":"Truong","year":"2022","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijcard.2021.08.018","article-title":"Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients","volume":"340","author":"Abbate","year":"2021","journal-title":"Int J Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.3346\/jkms.2021.36.e286","article-title":"Myocarditis-induced sudden death after BNT162b2 mRNA COVID-19 vaccination in Korea: case report focusing on histopathological findings","volume":"36","author":"Choi","year":"2021","journal-title":"J Korean Med Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.amjcard.2013.10.021","article-title":"In-hospital arrhythmia development and outcomes in pediatric patients with acute myocarditis","volume":"113","author":"Miyake","year":"2014","journal-title":"Am J Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s00431-020-03687-4","article-title":"Impact of ventricular arrhythmias on outcomes in children with myocarditis","volume":"179","author":"Othman","year":"2020","journal-title":"Eur J Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1161\/CIR.0000000000001001","article-title":"Diagnosis and management of myocarditis in children: a scientific statement from the American heart association","volume":"144","author":"Law","year":"2021","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1161\/CIR.0000000000000745","article-title":"Recognition and initial management of fulminant myocarditis: a scientific statement from the American heart association","volume":"141","author":"Kociol","year":"2020","journal-title":"Circulation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/S0025-6196(12)61286-5","article-title":"Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error","volume":"64","author":"Hauck","year":"1989","journal-title":"Mayo Clin Proc"},{"key":"B24","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/0735-1097(89)90465-8","article-title":"Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis","volume":"14","author":"Chow","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/pin.13234","article-title":"Myocarditis after COVID-19 mRNA vaccination in three young adult males: significance of biopsy in vaccine-associated myocarditis","volume":"72","author":"Amemiya","year":"2022","journal-title":"Pathol Int"},{"key":"B26","doi-asserted-by":"publisher","first-page":"925","DOI":"10.5858\/arpa.2021-0435-SA","article-title":"Autopsy histopathologic cardiac findings in 2 adolescents following the second COVID-19 vaccine dose","volume":"146","author":"Gill","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.cjco.2022.02.004","article-title":"Biopsy-proven fulminant myocarditis requiring mechanical circulatory support following COVID-19 mRNA vaccination","volume":"4","author":"Kazama","year":"2022","journal-title":"CJC Open"},{"key":"B28","doi-asserted-by":"publisher","first-page":"758996","DOI":"10.3389\/fcvm.2021.758996","article-title":"Case report: acute fulminant myocarditis and cardiogenic shock after messenger RNA coronavirus disease 2019 vaccination requiring extracorporeal cardiopulmonary resuscitation","volume":"8","author":"Lim","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1056\/NEJMc2109975","article-title":"Myocarditis after COVID-19 mRNA vaccination","volume":"385","author":"Verma","year":"2021","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/ejhf.2523","article-title":"Pathological findings of clinically suspected myocarditis temporally associated with COVID-19 vaccination","volume":"24","author":"Yamamoto","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"B31","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1161\/CIRCULATIONAHA.121.055913","article-title":"Myocarditis after BNT162b2 and mRNA-1273 vaccination","volume":"144","author":"Larson","year":"2021","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.121.055891","article-title":"Myocarditis temporally associated with COVID-19 vaccination","volume":"144","author":"Rosner","year":"2021","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.jacc.2012.01.007","article-title":"Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery","volume":"59","author":"Grun","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.jacc.2017.08.050","article-title":"Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis","volume":"70","author":"Grani","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.jacc.2017.08.044","article-title":"Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY study","volume":"70","author":"Aquaro","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1007\/s00246-022-02878-0","article-title":"CMR imaging 6 months after myocarditis associated with the BNT162b2 mRNA COVID-19 vaccine","volume":"43","author":"Amir","year":"2022","journal-title":"Pediatr Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1007\/s00431-022-04482-z","article-title":"Follow-up cardiac magnetic resonance in children with vaccine-associated myocarditis","volume":"181","author":"Hadley","year":"2022","journal-title":"Eur J Pediatr"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e004262","DOI":"10.1161\/CIRCHEARTFAILURE.117.004262","article-title":"Cardiac magnetic resonance imaging in myocarditis reveals persistent disease activity despite normalization of cardiac enzymes and inflammatory parameters at 3-month follow-up","volume":"10","author":"Berg","year":"2017","journal-title":"Circ Heart Fail"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s00246-020-02445-5","article-title":"Persistence of late gadolinium enhancement on follow-up CMR imaging in children with acute myocarditis","volume":"41","author":"Dubey","year":"2020","journal-title":"Pediatr Cardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/j.jacc.2019.08.1061","article-title":"Prognostic value of repeating cardiac magnetic resonance in patients with acute myocarditis","volume":"74","author":"Aquaro","year":"2019","journal-title":"J Am Coll Cardiol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.995167\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T06:45:39Z","timestamp":1669013139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.995167\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":40,"alternative-id":["10.3389\/fped.2022.995167"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.995167","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2022,11,21]]},"article-number":"995167"}}